Company Profile

Orbit Genomics Inc
Profile last edited on: 3/12/2025      CAGE: 83H19      UEI: MM1BNU8N23B3

Business Identifier: Leverage proprietary OrbiSeq™ technology platform for early disease detection, treatment and prevention of complex diseases
Year Founded
2018
First Award
2024
Latest Award
2024
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

4665 Nautilus Court S Suite 300
Boulder, CO 80301
   (720) 515-0395
   info@orbitgenomics.com
   www.orbitgenomics.com
Location: Single
Congr. District: 02
County: Boulder

Public Profile

Orbit Genomics technology platform enables early disease detection, treatment, and prevention of complex diseases. The platform analyzes repetitive DNA which uniquely reflects both inherited and acquired disease risk. They provides technology platform analyzes a different part of your DNA that uniquely reflects both inherited predisposition todisease.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2024 2 NIH $999,555
Project Title: Development of a lung cancer subtyping diagnostic

Key People / Management

  Elizabeth (Dede) Willis -- President & CEO and Board Member

  Randy Berholtz -- Co-Founder and Vice President Business Development and General Counsel

  Kyle Caltrider -- Director of Quality and IT

  Harold R Garner -- Chief Scientific Officer

  Deborah Johnson -- Laboratory Director

  Nicholas Kinney -- Director Of Bioinformatics

  Sarah Urfer -- Director Of Laboratory Operations

Company News

There are no news available.